Corticosteroid treatment for post-COVID-19 persistent interstitial lung disease: a randomized clinical trial
{{output}}
This study aimed to evaluate the efficacy of prednisolone in the treatment of persistent interstitial lung disease following severe SARS-CoV-2 pneumonia. A single-center, randomized, double-blind, placebo-controlled clinical trial was conducted. All participan... ...
